Prolonged vasopressor support during hip‐fracture surgery is a risk factor for enhanced mortality

Background Hip fracture is a common injury in the elderly population and is associated with high morbidity and mortality. Intraoperative hypotension is commonly noted, and is often treated with vasopressors (VP), however, to what extent is unknown. We set out to examine retrospectively how many hip fracture‐patients received VP perioperatively and further to investigate if VP treatment is connected to increased mortality. Method Data on VP treatment were captured from medical and anaesthesia journals, and if so, data were investigated to find potential confounders. Patients were divided into (a) no VP, (b) VP by injection, (c) VP by infusion